Luciole Medical has developed unique, easy-to-use and technologically advanced brain monitoring solutions that can provide clinicians with the tools they need to monitor cerebral blood flow and cerebral oxygen metabolism across hospital settings, helping to improve outcomes and save lives based on comprehensive brain observation. Luciole Medical products are approved for use in Europe.
The patch (RheoPatch) is a multiple-use sensor that is simply attached onto the skin and measures oxygen metabolism and blood flow of the subjacent tissue non-invasively. The non-invasive method of measuring critical brain parameters using the patch expands the applicability to a broader range of hospital settings, for example, pediatric and anesthesia. The patch may be used on its own, or in parallel with the probe to gain a thorough understanding of brain hemodynamics.
The probe (RheoSens) is used for patients with severe brain injuries and brain hemorrhage where the patients are unconscious. It is a sterile, implantable probe that is inserted with a suitable introducer kit into the brain (parenchymal) tissue. The procedure is identical to the installation of a conventional intracranial pressure (ICP) probe. Up to two probe devices may be used in parallel on one patient. While conventional probes only measure ICP, our probe can give additional important information to the clinician, as it measures ICP, brain temperature, oxygen metabolism and cerebral blood flow. The device is a disposable single use product which can be placed in the brain for up to 7 days.
RheoLity consists of user-friendly software that is used in conjunction with both patch and probe sensors.
The RheoLity software analyses cerebral blood flow and instant oxygen metabolism data captured by the sensors and displays the data on a standard medical PC in an intuitive and easy-to-interpret format.
Additionally, the platform manages patient information and patient measurements to improve clinician workflow.